[ad_1]
Download PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227
By application, the dietary supplements segment is estimated to dominate the omega-3 market.
In the Omega-3 market, a noticeable trend is emerging among consumers who are increasingly embracing proactive health management practices, leading to a surge in the consumption of dietary supplements. Omega-3 supplements are widely acknowledged for their potential health advantages, encompassing support for heart health, cognitive function, and joint health. Consequently, the demand for Omega-3 dietary supplements is witnessing significant growth. Regulatory agencies have endorsed health claims associated with Omega-3 fatty acids, reinforcing consumer trust in Omega-3 dietary supplements. These substantiated health assertions, such as promoting heart health and cognitive function, motivate consumers to integrate Omega-3 supplements into their daily routines. As a result, the dominance of the “dietary supplements” segment in the omega-3 market is expected to continue during the forecast period.
By type, Eicosapentaenoic Acid (EPA) is estimated to grow at the highest CAGR during the forecast period in terms of value.
Numerous clinical trials and research studies have provided strong evidence supporting the effectiveness of EPA in addressing various health conditions, including cardiovascular disease, inflammation, and mood disorders like depression. This wealth of scientific evidence reinforces the health benefits attributed to EPA, bolstering consumer confidence and driving market expansion. EPA’s therapeutic potential extends beyond cardiovascular health and encompasses the management of inflammatory conditions such as rheumatoid arthritis, inflammatory bowel disease, and asthma. Moreover, EPA has been investigated for its neuroprotective properties and its impact on mental health and cognitive function. The broadening scope of therapeutic applications for EPA contributes to its increasing demand in the Omega-3 market.
By source, the marine segment is projected to dominate the omega-3 market.
Marine sources, including fish oil, krill oil, and algae, naturally contain abundant omega-3 fatty acids, such as EPA and DHA. These marine organisms accumulate Omega-3 through their consumption of algae and phytoplankton, making them readily available sources of these essential nutrients. Omega-3 derived from marine sources typically boasts high bioavailability, ensuring easy absorption and utilization by the body, thus enhancing its effectiveness in delivering health benefits compared to other sources.
Furthermore, marine-derived omega-3 supplements, especially fish oil supplements, have been widely accessible in the market for many years. This longstanding presence has cultivated strong consumer trust, establishing them as the preferred option for individuals seeking Omega-3 supplementation, which contributes to the growth of the omega-3 market.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=227
The Asia Pacific region is projected to have the fastest growth in terms of value.
Regulatory agencies across the Asia Pacific region have endorsed health claims associated with Omega-3 fatty acids, which enhance consumer confidence in these products. These health claims, including heart health and cognitive function benefits, motivate consumers to integrate Omega-3 into their daily dietary routines. Additionally, the rise of chronic health conditions like cardiovascular disease, diabetes, and obesity, stemming from rapid urbanization, sedentary lifestyles, and dietary shifts, prompts consumers to increasingly seek out nutritional supplements such as Omega-3 to bolster their overall health and wellness in response to these lifestyle changes.
Key players in this market include BASF SE (Germany), Cargill, Incorporated. (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group Plc (Ireland), Croda International Plc (UK), Orkla. (Norway), Corbion (Netherlands), GC Rieber (Norway), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), Cooke Aquaculture Inc. (Canada), AlgiSys Biosciences, Inc. (US), Golden Omega (Chile), and Polaris (France).
About MarketsandMarkets
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the GIVE Growth principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[ad_2]
Source link
